Hassa 2009.
Study characteristics | |||
Patient sampling |
Primary objective: to investigate the changes in Th1 and Th2 immune responses, characterised by a change in the levels of IL‐2, IL‐4, IL‐10 and IFN‐γ, and determinations of T helper, T suppressor, NK, and B cells in peripheral blood and peritoneal fluid of different stages of endometriosis Participants: patients who underwent laparoscopy for pain or infertility (cases) and for tubal ligation (controls) Selection criteria: exclusion criteria: any medical treatment employed prior to laparoscopy that may interfere with the results Study design: cross‐sectional two‐gate, prospective collection of samples |
||
Patient characteristics and setting |
Clinical presentation: controls had no history of infertility and no pelvic pathology during surgical inspection Age: mean 30.9 ± 5.6; 29.9 ± 6.7 years (endometriosis stage I‐II; III‐IV), 30.1 ± 6.7 years (controls) Number of participants enrolled: 97 women Number of participants available for analysis: 97 women (all in follicular phase of menstrual cycle) Setting: O&G Department, Eskisehir Osmangazi University School of Medicine Place of study: Eskisehir, Turkey Period of study: 2003–2005 Language: English |
||
Index tests |
Index test: IL‐2, IL‐4, IL‐10, IFN‐γ, and lymphocytes: Th, Ts, AL and NK Details of the index test procedure as stated: cytokines were measured by using ELISA assay (Cellular Communication Investigations, Beckman Coulter, USA); lymphocytes were assessed by using cluster determinant‐3 (CD‐3), CD4, CD8, CD25, CD28, CD45, CD16, CD23, Abs against early T cell activation antigens such as CD45RA/CD45RO, CD‐69 and late activation antigens such as HLA‐DR; sensitivity limits of the kits were 5 pg/ml, 5 pg/ml, 5 pg/ml, and 0.08 pg/ml for IL‐2, IL‐4, IL‐10, IFN‐γ; sample handling and technique described Threshold for positive result: not provided Examiners: experienced technicians blind to the status of cases at laboratory conducted the detection of both cytokine and immune cell levels Interobserver variability: Intra‐ and interassay CVs were < 10% for all assays |
||
Target condition and reference standard(s) |
Target condition: endometriosis Prevalence of target condition in the sample: n = 60/97 (62%): stage I‐II 42, stage III‐IV 18; controls n = 37 Reference standard: laparoscopy N = 97 (100%) + histology Description of positive case definition by reference standard test as reported: visual inspection confirmed histopathologically; staging according to the rAFS classification Examiners: no information provided |
||
Flow and timing |
Time interval between index test and reference standard: not clearly stated, but from the context, blood was collected at surgery Withdrawals: none |
||
Comparative | |||
Key conclusions by the authors | The result of this study did not show any significant difference in peripheral blood and peritoneal fluid cytokine and lymphocyte subgroups between normal women and those with early and late stage endometriosis | ||
Conflict of interest | All the authors had a conflict of interest (financial or otherwise) | ||
Notes | For IL‐2, IL‐4, IL‐10, IFN‐γ, Th, Ts, AL, NK there was not statistically significant difference between the groups ‐ no data available for meta‐analysis | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | No | ||
Did the study avoid inappropriate exclusions? | Yes | ||
Was a 'two‐gate' design avoided? | No | ||
High | Low | ||
DOMAIN 2: Index Test All tests | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | No | ||
Was a cycle phase considered in interpretation of the result of index test? | Yes | ||
High | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Low | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Unclear |